StockVS

NYSE · Medical Instruments & Supplies · USD

Alcon Inc. (ALC) Stock Analysis

Alcon Inc. (ALC) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

ALC

$67.43

−$0.40 (−0.59%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ALC with… →

ALC Key Statistics

As of Oct 21, 2026
Trading
Open
$67.56
Previous Close
$67.83
Day's Range
67.09–68.09
52-Week Range
61.84–87.64
Volume
1.10M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.73
Valuation
Market Cap
$32.60B
P/E Ratio
51.08
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
17.01
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.22
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
3.00
EPS (ttm)Profit attributable to each share over the last twelve months.
1.32
Financials (FY)
Revenue (FY)
$10.40B+4.94%
Net Income (FY)
$980.00M−3.73%
Profit marginThe share of revenue left as profit after all costs and taxes.
5.92%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
483.40M
1-Year Return
−10.56%
Dividend and dates
Dividend
$0.36+0.53%
Ex-Dividend Date
May 6, 2026
Earnings Date
November 10, 2026
Avg Volume
1.77M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, ALC closed at $67.43, −10.56% over 1 year.

Alcon Inc. (ALC) has a market capitalization of $32.60B.

In fiscal 2025, ALC reported revenue of $10.40B.

ALC Stock Return by Calendar Year

Alcon Inc. (ALC) return since Apr 2019: what $10,000 became

1 year
$10,000 $8,944
−10.56%
5 years
$10,000 $8,417
−15.83%
Since Apr 2019
$10,000 $11,843
+18.43%

If you had invested $10,000 in Alcon Inc. (ALC) at the close on April 9, 2019, the earliest close on record here, it would have been worth $11,843 at the close on October 21, 2026: +18.43% in total, +2.27% a year, with dividends reinvested, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−14.02%
2025−6.84%
2024+9.02%
2023+14.32%
2022−21.09%
2021+32.23%
2020+16.63%
2019 (partial year)−2.53%

As of October 21, 2026.

ALC Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$10.40B$980.00M9.4%
2024$9.91B$1.02B10.3%
2023$9.46B$974.00M10.3%
2022$8.72B$335.00M3.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$10.40B$5.75B$1.36B$980.00M9.4%
2024$9.91B$5.51B$1.41B$1.02B10.3%
2023$9.46B$5.25B$1.04B$974.00M10.3%
2022$8.72B$4.75B$672.00M$335.00M3.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ALC Dividend History

$0.33+25.4% vs 2024

Dividends per share, 2025 · 1 payments

YearDividends per sharePaymentsChange
2026*$0.361—
2025$0.331+25.4%
2024$0.261+11.9%
2023$0.241+15.1%
YearDividends per sharePaymentsChange
2026 (partial year)$0.361—
2025$0.331+25.4%
2024$0.261+11.9%
2023$0.241+15.1%
2022$0.211+86.4%
2021$0.111—

Most recent payment: $0.36 per share, ex-dividend May 5, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

ALC Valuation vs Medical Instruments & Supplies Median

Median of 50 stocks
MetricALCMedical Instruments & Supplies medianvs median
P/E51.0831.1964% above
P/S ratio3.002.6016% above
Profit margin5.92%1.62%4.3 pts above

Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Alcon Inc. (ALC) carries a market capitalisation of $32.60B. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. The company reports 25,000 employees.

The 52-week range on file runs from $61.84 to $87.64. ALC last closed at $67.43 on October 21, 2026. That is −$0.40 (−0.59%) against the previous close. The latest close sits 9.05% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $10.40B. That is +4.94% against the prior fiscal year, when revenue was $9.91B. The same year closed with net income of $980.00M. That is −3.73% against the prior fiscal year. Profit margin runs at 5.92%. That is 4.3 percentage points above the Medical Instruments & Supplies median of 1.62%. Earnings per share on a trailing basis come to 1.32.

Across the 4 fiscal years on file, revenue moves from $8.72B in 2022 to $10.40B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 51.08. That is 63.77% above the Medical Instruments & Supplies median of 31.19. The forward P/E on file is 17.01. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.22. Measured against sales, the shares trade at 3 times revenue. On price-to-sales that is 15.53% above the Medical Instruments & Supplies median of 2.6. 50 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the total return is −10.56%. Measured over 5 years, that is −3.39% a year compounded. Beta against the wider market is reported at 0.73. Daily returns over the trailing 7 years annualize to a volatility of 28.23%.

Growth & Income

The trailing dividend yield is 0.53%. That is 0.5 percentage points below the Medical Instruments & Supplies median yield of 1.04%. At the indicated rate that is $0.36 a share a year. The ex-dividend date on file is May 6, 2026. Dividends are recorded for 6 calendar years; 2026 shows 1 payments totalling $0.36 a share. The year before, 2025, totalled $0.33 a share.

2026 is still running; the total return is −14.02% year to date. Across the complete calendar years on file, 2021 returned +32.23% and 2022 returned −21.09%. Of the 6 complete calendar years on file, 4 finished higher.

Peer Comparison

Alcon Inc. (ALC) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Alcon Inc. ALC $32.60B 51.1
Intuitive Surgical, Inc. ISRG $151.25B 51.8
Becton, Dickinson and Company BDX $52.79B 45.1
Medline Inc. MDLN $47.51B 88.3

The Medical Instruments & Supplies industry average P/E ratio is 31.2x. Alcon Inc. trades at a P/E of 51.1.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Instruments & Supplies Stocks

View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Alcon Inc.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Visit website →